U.S. federal trademark · Serial No. 74285119
pharmaceutical preparations for the treatment of metabolic disorders; namely, impaired glucose tolerance, insulin resistance, type 2 diabetes mellitus, obesity, hypertension and other conditions characterized by excess amylin or excess amylin action
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.